Iravani, Amir <br/><br/>
FDG PET/CT for tumoral and systemic immune response monitoring of advanced melanoma during first-line combination ipilimumab and nivolumab treatment.  [electronic resource] 

 -  European journal of nuclear medicine and molecular imaging  11 2020 
 - 2776-2786 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1619-7089 
<br/><br/><label>Standard No.: </label>10.1007/s00259-020-04815-w  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Fluorodeoxyglucose F18<br/>Humans<br/>Immunity<br/>Ipilimumab--adverse effects<br/>Melanoma--diagnostic imaging<br/>Middle Aged<br/>Nivolumab--therapeutic use<br/>Positron Emission Tomography Computed Tomography<br/>Retrospective Studies<br/>Treatment Outcome